Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Differences in CYP3A genotypes of a liver transplant recipient and the donor liver graft and adjustment of tacrolimus dose.

Berger FA, Mulder MB, Ten Bosch-Dijksman W, van Schaik RHN, Coenen S, de Winter BCM.

Br J Clin Pharmacol. 2019 Jun 12. doi: 10.1111/bcp.13958. [Epub ahead of print]

PMID:
31190414
2.

Comparison of hypersensitivity reactions of intravenous iron: iron isomaltoside-1000 (Monofer® ) versus ferric carboxy-maltose (Ferinject® ). A single center, cohort study.

Mulder MB, van den Hoek HL, Birnie E, van Tilburg AJP, Westerman EM.

Br J Clin Pharmacol. 2019 Feb;85(2):385-392. doi: 10.1111/bcp.13805. Epub 2018 Dec 11.

PMID:
30393904
3.
4.

Therapeutic Drug Monitoring of methotrexate in plasma using U-HPLC-MS/MS: necessary after administration of glucarpidase in methotrexate intoxications.

Mulder MB, Huisman R, Engels FK, van der Sluis IM, Koch BCP.

Ther Drug Monit. 2018 Apr 3. doi: 10.1097/FTD.0000000000000515. [Epub ahead of print]

PMID:
29621124
5.

In vitro pharmacokinetics/pharmacodynamics of the combination of avibactam and aztreonam against MDR organisms.

Sy SK, Beaudoin ME, Zhuang L, Löblein KI, Lux C, Kissel M, Tremmel R, Frank C, Strasser S, Heuberger JA, Mulder MB, Schuck VJ, Derendorf H.

J Antimicrob Chemother. 2016 Jul;71(7):1866-80. doi: 10.1093/jac/dkw082. Epub 2016 Apr 21.

PMID:
27107096
6.

Evaluation of in vitro synergy between vertilmicin and ceftazidime against Pseudomonas aeruginosa using a semi-mechanistic pharmacokinetic/pharmacodynamic model.

Zhuang L, Sy SK, Xia H, Singh RP, Mulder MB, Liu C, Derendorf H.

Int J Antimicrob Agents. 2015 Feb;45(2):151-60. doi: 10.1016/j.ijantimicag.2014.09.017. Epub 2014 Nov 1.

PMID:
25465523

Supplemental Content

Loading ...
Support Center